FIELD: medicine; gastroenterology.
SUBSTANCE: invention can be used for the diagnostics of non-alcoholic fatty liver disease in metabolic syndrome. To diagnose the stage of non-alcoholic fatty liver disease, the concentration of ammonia in capillary blood is determined. At its level from 55.0 to 80.0 µmol/l, liver steatosis is diagnosed, at its level from 81.0 to 177.0 µmol/l, non-alcoholic steatohepatitis is diagnosed, at its level from 178 µmol/l and above, liver cirrhosis is diagnosed.
EFFECT: method enables to diagnose the following stages of non-alcoholic fatty liver disease: hepatic steatosis, non-alcoholic steatohepatitis, cirrhosis of the liver by determining the concentration of ammonia in capillary blood.
1 cl, 2 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 | 
 | RU2744021C1 | 
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 | 
 | RU2753455C1 | 
| METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 | 
 | RU2765847C1 | 
| METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 | 
 | RU2768466C1 | 
| METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS | 2017 | 
 | RU2675015C1 | 
| METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 | 
 | RU2765848C1 | 
| METHOD FOR DETERMINATION OF ATHEROSCLEROTIC DAMAGE OF VASCULAR WALL IN PATIENTS WITH ABDOMINAL OBESITY AND NONALCOLORAL FAT LIVER DISEASE (VERSIONS) | 2016 | 
 | RU2637412C1 | 
| METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 | 
 | RU2798723C1 | 
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 | 
 | RU2686042C1 | 
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 | 
 | RU2813033C1 | 
Authors
Dates
2023-09-22—Published
2022-05-12—Filed